CRIS Stock Analysis: Buy, Sell, or Hold?
CRIS - Curis Inc
$0.32
0.12 (55.98%)
▲
5d:
-23.75%
30d:
-39.2%
90d:
-44.66%
WAIT
LOW Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CRIS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRIS is down 23.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRIS is down 23.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRIS is currently trading at $0.32, which is considered oversold relative to its 30-day fair value range of $0.37 to $0.52.
Technical Outlook: Technically, CRIS is in a strong downtrend. The price is currently testing key support at $0.38. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 56.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+4261.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRIS is in a strong downtrend. The price is currently testing key support at $0.38. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 56.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+4261.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.37 -
$0.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+56.0%)
- BULLISH: Trading 4261.4% below Wall St target ($14.00)
- WARNING: Recommendation downgraded due to -23.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.37 -
$0.52
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$0.54
Current Trend
Strong Downtrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.27
Wall Street Target
$14.00
(+4261.4%)
Revenue Growth (YoY)
-66.0%
Profit Margin
-299.7%
Share & Embed Analysis
Last updated: June 27, 2026 5:15 AM ET
Data refreshes hourly during market hours. Next update: 6:15 AM
Data refreshes hourly during market hours. Next update: 6:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRIS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 65 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 67 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 57 HOLD |
